S&P 500   3,795.54
DOW   30,991.52
QQQ   314.35
S&P 500   3,795.54
DOW   30,991.52
QQQ   314.35
S&P 500   3,795.54
DOW   30,991.52
QQQ   314.35
S&P 500   3,795.54
DOW   30,991.52
QQQ   314.35
Log in
NYSE:BSX

Boston Scientific Stock Forecast, Price & News

$36.11
-0.05 (-0.14 %)
(As of 01/15/2021 09:00 AM ET)
Add
Compare
Today's Range
$36.11
Now: $36.11
$36.11
50-Day Range
$33.15
MA: $34.91
$36.76
52-Week Range
$24.10
Now: $36.11
$44.44
Volume87 shs
Average Volume11.52 million shs
Market Capitalization$51.71 billion
P/E Ratio13.84
Dividend YieldN/A
Beta0.87
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Boston Scientific logo

MarketRank

Overall MarketRank

2.19 out of 5 stars

Medical Sector

23rd out of 1,479 stocks

Surgical & Medical Instruments Industry

4th out of 135 stocks

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP10113710
Phone508-683-4000
Employees36,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.74 billion
Cash Flow$2.36 per share
Book Value$9.96 per share

Profitability

Net Income$4.70 billion

Miscellaneous

Outstanding Shares1,431,921,000
Market Cap$51.71 billion
Next Earnings Date2/3/2021 (Estimated)
OptionableOptionable
$36.11
-0.05 (-0.14 %)
(As of 01/15/2021 09:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BSX News and Ratings via Email

Sign-up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Boston Scientific (NYSE:BSX) Frequently Asked Questions

How has Boston Scientific's stock price been impacted by Coronavirus (COVID-19)?

Boston Scientific's stock was trading at $33.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BSX stock has increased by 6.8% and is now trading at $36.16.
View which stocks have been most impacted by COVID-19
.

Is Boston Scientific a buy right now?

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 3 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Boston Scientific stock.
View analyst ratings for Boston Scientific
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Boston Scientific?

Wall Street analysts have given Boston Scientific a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Boston Scientific wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Boston Scientific's next earnings date?

Boston Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Boston Scientific
.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) posted its quarterly earnings data on Monday, November, 2nd. The medical equipment provider reported $0.37 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.12. The medical equipment provider had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.52 billion. Boston Scientific had a net margin of 36.59% and a return on equity of 11.77%.
View Boston Scientific's earnings history
.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific updated its fourth quarter 2020 Pre-Market earnings guidance on Tuesday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.71-2.71 billion, compared to the consensus revenue estimate of $2.86 billion.

What price target have analysts set for BSX?

23 equities research analysts have issued twelve-month price objectives for Boston Scientific's shares. Their forecasts range from $25.00 to $58.00. On average, they anticipate Boston Scientific's stock price to reach $43.46 in the next year. This suggests a possible upside of 20.2% from the stock's current price.
View analysts' price targets for Boston Scientific
or view Wall Street analyst' top-rated stocks.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 16,340,000 shares, an increase of 33.7% from the December 15th total of 12,220,000 shares. Based on an average trading volume of 13,170,000 shares, the days-to-cover ratio is currently 1.2 days.
View Boston Scientific's Short Interest
.

Who are some of Boston Scientific's key competitors?

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), The Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and salesforce.com (CRM).

Who are Boston Scientific's key executives?

Boston Scientific's management team includes the following people:
  • Mr. Michael F. Mahoney, Chairman, Pres & CEO (Age 56, Pay $3.57M)
  • Mr. Daniel J. Brennan, Exec. VP & CFO (Age 55, Pay $1.28M)
  • Mr. Edward F. Mackey, Exec. VP of Global Operations (Age 58, Pay $1.13M)
  • Mr. Joseph M. Fitzgerald, Exec. VP & Pres of Interventional Cardiology (Age 57, Pay $1.24M)
  • Mr. Jonathan R. Monson, VP, Global Controller & Chief Accounting Officer
  • Ms. Jodi Euerle Eddy, Sr. VP and Chief Information & Digital Officer (Age 48)
  • Ms. Susan Vissers Lisa, VP of Investor Relations
  • Ms. Desiree Ralls-Morrison, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Catherine Jennings, VP of Global Marketing & New Bus. Devel. of Peripheral Interventions
  • Ms. Wendy Carruthers, Sr. VP of HR (Age 52)

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a variety of institutional and retail investors. Top institutional investors include Gateway Investment Advisers LLC (0.06%), Atalanta Sosnoff Capital LLC (0.04%), Nexus Investment Management ULC (0.03%), State of Alaska Department of Revenue (0.02%), Gradient Investments LLC (0.01%) and IFM Investors Pty Ltd (0.01%). Company insiders that own Boston Scientific stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, Desiree Ralls-Morrison, Edward F Mackey, Eric Francis Yves Thepaut, Halliday Hamish, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Joseph Michael Fitzgerald, Kevin J Ballinger, Maulik Nanavaty, Wendy Carruthers, Williamson Scott and Xin Warren Wang.
View institutional ownership trends for Boston Scientific
.

Which major investors are selling Boston Scientific stock?

BSX stock was sold by a variety of institutional investors in the last quarter, including Atalanta Sosnoff Capital LLC, New England Research & Management Inc., Gateway Investment Advisers LLC, State of Alaska Department of Revenue, Gradient Investments LLC, Diversified Trust Co, Huntington National Bank, and Carlson Capital Management. Company insiders that have sold Boston Scientific company stock in the last year include Daniel J Brennan, David A Pierce, Jeffrey B Mirviss, John Bradley Sorenson, Joseph Michael Fitzgerald, Maulik Nanavaty, and Wendy Carruthers.
View insider buying and selling activity for Boston Scientific
or view top insider-selling stocks.

Which major investors are buying Boston Scientific stock?

BSX stock was purchased by a variety of institutional investors in the last quarter, including First American Bank, Nexus Investment Management ULC, IFM Investors Pty Ltd, HGK Asset Management Inc., Louisiana State Employees Retirement System, KMG Fiduciary Partners LLC, Private Trust Co. NA, and Fulton Bank N.A..
View insider buying and selling activity for Boston Scientific
or or view top insider-buying stocks.

How do I buy shares of Boston Scientific?

Shares of BSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $36.16.

How big of a company is Boston Scientific?

Boston Scientific has a market capitalization of $51.78 billion and generates $10.74 billion in revenue each year. The medical equipment provider earns $4.70 billion in net income (profit) each year or $1.58 on an earnings per share basis. Boston Scientific employs 36,000 workers across the globe.

What is Boston Scientific's official website?

The official website for Boston Scientific is www.bostonscientific.com.

How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at 508-683-4000 or via email at [email protected]

This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.